Target Name: KCNJ8
NCBI ID: G3764
Review Report on KCNJ8 Target / Biomarker Content of Review Report on KCNJ8 Target / Biomarker
KCNJ8
Other Name(s): Inward rectifier K(+) channel Kir6.1 | uKATP-1 | KIR6.1 | potassium channel, inwardly rectifying subfamily J member 8 | inwardly rectifying potassium channel KIR6.1 | Potassium inwardly rectifying channel subfamily J member 8 | potassium inwardly rectifying channel subfamily J member 8 | Kir6.1 | potassium voltage-gated channel subfamily J member 8 | inward rectifier K(+) channel Kir6.1 | KCNJ8_HUMAN | ATP-sensitive inward rectifier potassium channel 8 | Potassium channel, inwardly rectifying subfamily J member 8

KCNJ8 Plays A Crucial Role in Nervous System Function

The K(+) channel Kir6.1, also known as KCNJ8, is a protein that is expressed in various tissues and cells of the body. It plays a crucial role in the function of the nervous system, specifically in the inhibition of action potentials . The inhibition of action potentials is a critical function of the nervous system, as it allows for the regulation of muscle contractions, the transmission of signals in the brain, and the control of various physiological processes.

KCNJ8 is a voltage-dependent channel that is involved in the regulation of action potentials. It is a member of the superfamily of ion channels, known as the selective cation channels (SCs), and is responsible for the rapid and efficient regulation of the resting membrane potential of the channel. The channel is composed of a transmembrane protein domain and an intracellular loop, which is responsible for the regulation of the channel's activity.

The K(+) channel Kir6.1 is expressed in a variety of tissues and cells of the body, including the brain, heart, pancreas, and muscle. It is highly targeted and is involved in the regulation of a wide range of physiological processes , including neuronal excitability, muscle contractions, and the regulation of ion channels.

One of the key functions of the K(+) channel Kir6.1 is its role in the regulation of action potentials. This channel is involved in the rapid and efficient regulation of the resting membrane potential of the channel, which is the distance between the potential of the positively charged and negatively charged ions in the channel. The regulation of the resting membrane potential by the K(+) channel is critical for the normal function of the nervous system.

In addition to its role in the regulation of action potentials, the K(+) channel Kir6.1 is also involved in the regulation of other physiological processes. For example, it is involved in the regulation of muscle contractions, which is critical for movement and maintain posture. The channel is also involved in the regulation of the release of hormones from the pancreas, which is critical for the regulation of blood sugar levels.

The K(+) channel Kir6.1 is a drug target of interest, and research has shown that it is involved in a wide range of physiological processes. Studies have shown that the channel is involved in the regulation of neuronal excitability, muscle contractions, and the regulation of ion channels. In addition, the channel is also involved in the regulation of the release of hormones from the pancreas, which is critical for the regulation of blood sugar levels.

The K(+) channel Kir6.1 is also a potential biomarker for a variety of diseases, including epilepsy, bipolar disorder, and heart disease. Studies have shown that the channel is involved in the regulation of these conditions, and that its regulation is disrupted in these conditions.

In conclusion, the K(+) channel Kir6.1 is a critical protein that is involved in the regulation of action potentials and the regulation of a wide range of physiological processes. It is highly targeted and is expressed in various tissues and cells of the body. The channel is also involved in the regulation of muscle contractions, the release of hormones from the pancreas, and the regulation of neuronal excitability. The K(+) channel is a potential drug target and a potential biomarker for a variety of diseases. Further research is needed to fully understand the role of the K(+) channel Kir6.1 in the regulation of physiological processes and its potential as a drug target and biomarker.

Protein Name: Potassium Inwardly Rectifying Channel Subfamily J Member 8

Functions: This potassium channel is controlled by G proteins. Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it. Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is raised, the voltage range of the channel opening shifts to more positive voltages. The inward rectification is mainly due to the blockage of outward current by internal magnesium. Can be blocked by external barium (By similarity)

The "KCNJ8 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KCNJ8 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

KCNJ9 | KCNK1 | KCNK10 | KCNK12 | KCNK13 | KCNK15 | KCNK15-AS1 | KCNK16 | KCNK17 | KCNK18 | KCNK2 | KCNK3 | KCNK4 | KCNK5 | KCNK6 | KCNK7 | KCNK9 | KCNMA1 | KCNMB1 | KCNMB2 | KCNMB2-AS1 | KCNMB3 | KCNMB4 | KCNN1 | KCNN2 | KCNN3 | KCNN4 | KCNQ Channels (K(v) 7) | KCNQ1 | KCNQ1DN | KCNQ1OT1 | KCNQ2 | KCNQ3 | KCNQ4 | KCNQ5 | KCNQ5-AS1 | KCNQ5-IT1 | KCNRG | KCNS1 | KCNS2 | KCNS3 | KCNT1 | KCNT2 | KCNU1 | KCNV1 | KCNV2 | KCP | KCTD1 | KCTD10 | KCTD11 | KCTD12 | KCTD13 | KCTD13-DT | KCTD14 | KCTD15 | KCTD16 | KCTD17 | KCTD18 | KCTD19 | KCTD2 | KCTD20 | KCTD21 | KCTD21-AS1 | KCTD3 | KCTD4 | KCTD5 | KCTD5P1 | KCTD6 | KCTD7 | KCTD8 | KCTD9 | KDELR1 | KDELR2 | KDELR3 | KDF1 | KDM1A | KDM1B | KDM2A | KDM2B | KDM3A | KDM3B | KDM4A | KDM4B | KDM4C | KDM4D | KDM4E | KDM5A | KDM5A-GATAD1-EMSY chromatin complex | KDM5B | KDM5C | KDM5D | KDM6A | KDM6B | KDM7A | KDM7A-DT | KDM8 | KDR | KDSR | KEAP1 | Kelch-like protein